Eisai Co., Ltd. Logo

Eisai Co., Ltd.

ESALF

(2.8)
Stock Price

30,00 USD

2.79% ROA

3.78% ROE

48.08x PER

Market Cap.

1.566.618.170.258,30 USD

20.36% DER

2.92% Yield

4.45% NPM

Eisai Co., Ltd. Stock Analysis

Eisai Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Eisai Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (12%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

ROE in an average range (6.1%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (5.06%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 PBV

The stock's PBV ratio (2.71x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

5 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

6 Net Profit Growth

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

7 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

8 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

9 Dividend

The company's track record of consistently paying dividends in the last three years highlights its dedication to providing investors with regular income.

10 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (108.036), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

11 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

Eisai Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Eisai Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Eisai Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Eisai Co., Ltd. Revenue
Year Revenue Growth
2000 302.470.000.000
2001 361.844.000.000 16.41%
2002 431.673.000.000 16.18%
2003 466.479.000.000 7.46%
2004 500.127.000.000 6.73%
2005 533.139.000.000 6.19%
2006 601.258.000.000 11.33%
2007 674.175.000.000 10.82%
2008 734.419.000.000 8.2%
2009 781.708.000.000 6.05%
2010 803.138.000.000 2.67%
2011 768.925.000.000 -4.45%
2012 647.925.000.000 -18.68%
2013 573.676.000.000 -12.94%
2014 599.490.000.000 4.31%
2015 548.465.000.000 -9.3%
2016 547.922.000.000 -0.1%
2017 539.097.000.000 -1.64%
2018 600.054.000.000 10.16%
2019 642.834.000.000 6.65%
2020 695.621.000.000 7.59%
2021 645.942.000.000 -7.69%
2022 756.226.000.000 14.58%
2023 706.468.000.000 -7.04%
2023 744.402.000.000 5.1%
2024 741.751.000.000 -0.36%
2025 756.116.000.000 1.9%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Eisai Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2000 46.703.000.000
2001 49.613.000.000 5.87%
2002 55.035.000.000 9.85%
2003 59.704.000.000 7.82%
2004 69.018.000.000 13.5%
2005 78.325.000.000 11.88%
2006 93.249.000.000 16%
2007 108.296.000.000 13.89%
2008 225.427.000.000 51.96%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 120.377.000.000 100%
2014 136.310.000.000 11.69%
2015 131.907.000.000 -3.34%
2016 110.857.000.000 -18.99%
2017 104.273.000.000 -6.31%
2018 131.089.000.000 20.46%
2019 127.625.000.000 -2.71%
2020 125.490.000.000 -1.7%
2021 138.822.000.000 9.6%
2022 158.030.000.000 12.15%
2023 166.512.000.000 5.09%
2023 156.691.000.000 -6.27%
2024 153.092.000.000 -2.35%
2025 166.944.000.000 8.3%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Eisai Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 127.050.000.000
2001 154.661.000.000 17.85%
2002 202.459.000.000 23.61%
2003 228.443.000.000 11.37%
2004 250.865.000.000 8.94%
2005 269.392.000.000 6.88%
2006 307.795.000.000 12.48%
2007 351.249.000.000 12.37%
2008 372.303.000.000 5.66%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 139.849.000.000 100%
2014 203.335.000.000 31.22%
2015 194.546.000.000 -4.52%
2016 192.817.000.000 -0.9%
2017 174.942.000.000 -10.22%
2018 183.857.000.000 4.85%
2019 228.208.000.000 19.43%
2020 256.297.000.000 10.96%
2021 281.630.000.000 9%
2022 366.430.000.000 23.14%
2023 371.144.000.000 1.27%
2023 358.292.000.000 -3.59%
2024 374.421.000.000 4.31%
2025 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Eisai Co., Ltd. EBITDA
Year EBITDA Growth
2000 39.805.000.000
2001 78.930.000.000 49.57%
2002 80.061.000.000 1.41%
2003 94.159.000.000 14.97%
2004 101.879.000.000 7.58%
2005 111.496.000.000 8.63%
2006 125.193.000.000 10.94%
2007 137.183.000.000 8.74%
2008 54.008.000.000 -154%
2009 148.845.000.000 63.72%
2010 144.720.000.000 -2.85%
2011 163.881.000.000 11.69%
2012 145.615.000.000 -12.54%
2013 125.318.000.000 -16.2%
2014 108.115.000.000 -15.91%
2015 69.707.000.000 -55.1%
2016 76.843.000.000 9.29%
2017 77.689.000.000 1.09%
2018 101.778.000.000 23.67%
2019 126.762.000.000 19.71%
2020 172.379.000.000 26.46%
2021 92.842.000.000 -85.67%
2022 98.021.000.000 5.28%
2023 71.000.000.000 -38.06%
2023 79.201.000.000 10.35%
2024 86.150.000.000 8.07%
2025 72.216.000.000 -19.29%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Eisai Co., Ltd. Gross Profit
Year Gross Profit Growth
2000 210.789.000.000
2001 263.243.000.000 19.93%
2002 330.104.000.000 20.25%
2003 364.012.000.000 9.32%
2004 402.946.000.000 9.66%
2005 434.525.000.000 7.27%
2006 496.749.000.000 12.53%
2007 564.808.000.000 12.05%
2008 615.481.000.000 8.23%
2009 629.294.000.000 2.19%
2010 642.410.000.000 2.04%
2011 601.146.000.000 -6.86%
2012 474.572.000.000 -26.67%
2013 399.565.000.000 -18.77%
2014 404.831.000.000 1.3%
2015 354.870.000.000 -14.08%
2016 339.839.000.000 -4.42%
2017 331.091.000.000 -2.64%
2018 386.599.000.000 14.36%
2019 446.436.000.000 13.4%
2020 510.352.000.000 12.52%
2021 465.186.000.000 -9.71%
2022 569.791.000.000 18.36%
2023 560.760.000.000 -1.61%
2023 543.475.000.000 -3.18%
2024 563.774.000.000 3.6%
2025 597.088.000.000 5.58%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Eisai Co., Ltd. Net Profit
Year Net Profit Growth
2000 11.275.000.000
2001 23.087.000.000 51.16%
2002 36.512.000.000 36.77%
2003 41.027.000.000 11%
2004 50.148.000.000 18.19%
2005 55.505.000.000 9.65%
2006 63.410.000.000 12.47%
2007 70.614.000.000 10.2%
2008 -17.012.000.000 515.08%
2009 47.678.000.000 135.68%
2010 40.338.000.000 -18.2%
2011 67.394.000.000 40.15%
2012 58.511.000.000 -15.18%
2013 48.275.000.000 -21.2%
2014 38.251.000.000 -26.21%
2015 43.254.000.000 11.57%
2016 54.933.000.000 21.26%
2017 39.358.000.000 -39.57%
2018 51.845.000.000 24.09%
2019 63.386.000.000 18.21%
2020 121.767.000.000 47.94%
2021 41.942.000.000 -190.32%
2022 47.954.000.000 12.54%
2023 11.156.000.000 -329.85%
2023 55.432.000.000 79.87%
2024 42.407.000.000 -30.71%
2025 42.324.000.000 -0.2%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Eisai Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 152
2001 312 51.13%
2002 501 37.8%
2003 553 9.58%
2004 697 20.66%
2005 777 10.18%
2006 887 12.51%
2007 991 10.49%
2008 -239 514.64%
2009 669 135.72%
2010 566 -18.2%
2011 946 40.17%
2012 821 -15.23%
2013 678 -21.27%
2014 537 -26.31%
2015 606 11.55%
2016 192 -215.63%
2017 138 -40.15%
2018 181 24.31%
2019 221 18.1%
2020 425 48%
2021 147 -191.1%
2022 167 12.57%
2023 79 -114.1%
2023 193 59.59%
2024 148 -31.29%
2025 148 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Eisai Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2000 10.872.000.000
2001 71.079.000.000 84.7%
2002 31.446.000.000 -126.04%
2003 31.446.000.000 0%
2004 47.591.000.000 33.92%
2005 9.995.000.000 -376.15%
2006 43.216.000.000 76.87%
2007 52.630.000.000 17.89%
2008 19.507.000.000 -169.8%
2009 59.237.000.000 67.07%
2010 76.688.000.000 22.76%
2011 100.097.000.000 23.39%
2012 71.137.000.000 -40.71%
2013 53.354.000.000 -33.33%
2014 63.892.000.000 16.49%
2015 57.597.000.000 -10.93%
2016 55.545.000.000 -3.69%
2017 55.850.000.000 0.55%
2018 124.916.000.000 55.29%
2019 76.092.000.000 -64.16%
2020 52.556.000.000 -44.78%
2021 35.709.000.000 -47.18%
2022 77.123.000.000 53.7%
2023 -36.331.000.000 312.28%
2023 13.260.000.000 373.99%
2024 31.170.000.000 57.46%
2025 -13.195.000.000 336.23%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Eisai Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2000 27.174.000.000
2001 84.996.000.000 68.03%
2002 57.606.000.000 -47.55%
2003 57.606.000.000 0%
2004 72.718.000.000 20.78%
2005 49.200.000.000 -47.8%
2006 87.053.000.000 43.48%
2007 81.188.000.000 -7.22%
2008 73.242.000.000 -10.85%
2009 104.988.000.000 30.24%
2010 107.947.000.000 2.74%
2011 123.157.000.000 12.35%
2012 90.624.000.000 -35.9%
2013 73.181.000.000 -23.84%
2014 91.276.000.000 19.82%
2015 76.022.000.000 -20.07%
2016 95.617.000.000 20.49%
2017 75.851.000.000 -26.06%
2018 149.649.000.000 49.31%
2019 103.714.000.000 -44.29%
2020 102.782.000.000 -0.91%
2021 73.853.000.000 -39.17%
2022 117.590.000.000 37.19%
2023 -1.772.000.000 6736%
2023 16.620.000.000 110.66%
2024 55.993.000.000 70.32%
2025 -8.581.000.000 752.52%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Eisai Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2000 16.302.000.000
2001 13.917.000.000 -17.14%
2002 26.160.000.000 46.8%
2003 26.160.000.000 0%
2004 25.127.000.000 -4.11%
2005 39.205.000.000 35.91%
2006 43.837.000.000 10.57%
2007 28.558.000.000 -53.5%
2008 53.735.000.000 46.85%
2009 45.751.000.000 -17.45%
2010 31.259.000.000 -46.36%
2011 23.060.000.000 -35.56%
2012 19.487.000.000 -18.34%
2013 19.827.000.000 1.71%
2014 27.384.000.000 27.6%
2015 18.425.000.000 -48.62%
2016 40.072.000.000 54.02%
2017 20.001.000.000 -100.35%
2018 24.733.000.000 19.13%
2019 27.622.000.000 10.46%
2020 50.226.000.000 45%
2021 38.144.000.000 -31.67%
2022 40.467.000.000 5.74%
2023 34.559.000.000 -17.1%
2023 3.360.000.000 -928.54%
2024 24.823.000.000 86.46%
2025 4.614.000.000 -437.99%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Eisai Co., Ltd. Equity
Year Equity Growth
2000 338.898.000.000
2001 355.037.000.000 4.55%
2002 371.245.000.000 4.37%
2003 397.579.000.000 6.62%
2004 419.461.000.000 5.22%
2005 459.607.000.000 8.73%
2006 519.215.000.000 11.48%
2007 562.698.000.000 7.73%
2008 453.791.000.000 -24%
2009 433.045.000.000 -4.79%
2010 421.740.000.000 -2.68%
2011 410.370.000.000 -2.77%
2012 423.426.000.000 3.08%
2013 474.301.000.000 10.73%
2014 529.404.000.000 10.41%
2015 602.062.000.000 12.07%
2016 576.828.000.000 -4.37%
2017 602.591.000.000 4.28%
2018 614.098.000.000 1.87%
2019 651.982.000.000 5.81%
2020 702.630.000.000 7.21%
2021 727.942.000.000 3.48%
2022 771.533.000.000 5.65%
2023 884.845.000.000 12.81%
2023 822.571.000.000 -7.57%
2024 898.975.000.000 8.5%
2025 919.696.000.000 2.25%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Eisai Co., Ltd. Assets
Year Assets Growth
2000 485.673.000.000
2001 549.444.000.000 11.61%
2002 557.609.000.000 1.46%
2003 591.721.000.000 5.76%
2004 615.776.000.000 3.91%
2005 662.711.000.000 7.08%
2006 747.231.000.000 11.31%
2007 792.114.000.000 5.67%
2008 1.123.939.000.000 29.52%
2009 1.148.163.000.000 2.11%
2010 1.101.910.000.000 -4.2%
2011 1.046.291.000.000 -5.32%
2012 1.004.660.000.000 -4.14%
2013 990.249.000.000 -1.46%
2014 973.823.000.000 -1.69%
2015 1.053.818.000.000 7.59%
2016 973.987.000.000 -8.2%
2017 1.030.764.000.000 5.51%
2018 1.049.031.000.000 1.74%
2019 1.071.520.000.000 2.1%
2020 1.062.140.000.000 -0.88%
2021 1.090.009.000.000 2.56%
2022 1.239.315.000.000 12.05%
2023 1.333.993.000.000 7.1%
2023 1.263.350.000.000 -5.59%
2024 1.393.799.000.000 9.36%
2025 1.420.247.000.000 1.86%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Eisai Co., Ltd. Liabilities
Year Liabilities Growth
2000 146.775.000.000
2001 203.549.000.000 27.89%
2002 186.364.000.000 -9.22%
2003 203.474.000.000 8.41%
2004 196.315.000.000 -3.65%
2005 203.104.000.000 3.34%
2006 228.016.000.000 10.93%
2007 229.416.000.000 0.61%
2008 670.148.000.000 65.77%
2009 715.118.000.000 6.29%
2010 680.170.000.000 -5.14%
2011 635.921.000.000 -6.96%
2012 581.233.000.000 -9.41%
2013 515.946.000.000 -12.65%
2014 444.419.000.000 -16.09%
2015 451.756.000.000 1.62%
2016 397.159.000.000 -13.75%
2017 428.172.000.000 7.24%
2018 434.934.000.000 1.55%
2019 419.539.000.000 -3.67%
2020 359.509.000.000 -16.7%
2021 362.067.000.000 0.71%
2022 467.781.000.000 22.6%
2023 449.148.000.000 -4.15%
2023 440.779.000.000 -1.9%
2024 494.825.000.000 10.92%
2025 500.551.000.000 1.14%

Eisai Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2562.78
Net Income per Share
114.02
Price to Earning Ratio
48.08x
Price To Sales Ratio
2.13x
POCF Ratio
45.15
PFCF Ratio
64.2
Price to Book Ratio
1.75
EV to Sales
1.97
EV Over EBITDA
22.27
EV to Operating CashFlow
41.56
EV to FreeCashFlow
59.21
Earnings Yield
0.02
FreeCashFlow Yield
0.02
Market Cap
1.566,62 Bil.
Enterprise Value
1.445,02 Bil.
Graham Number
2832.85
Graham NetNet
184.04

Income Statement Metrics

Net Income per Share
114.02
Income Quality
1.07
ROE
0.04
Return On Assets
0.02
Return On Capital Employed
0.02
Net Income per EBT
0.66
EBT Per Ebit
1.97
Ebit per Revenue
0.03
Effective Tax Rate
0.31

Margins

Sales, General, & Administrative to Revenue
0.39
Research & Developement to Revenue
0.23
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.79
Operating Profit Margin
0.03
Pretax Profit Margin
0.07
Net Profit Margin
0.04

Dividends

Dividend Yield
0.03
Dividend Yield %
2.92
Payout Ratio
1.41
Dividend Per Share
1.08

Operating Metrics

Operating Cashflow per Share
121.43
Free CashFlow per Share
85.22
Capex to Operating CashFlow
0.3
Capex to Revenue
0.01
Capex to Depreciation
0.26
Return on Invested Capital
0.02
Return on Tangible Assets
0.03
Days Sales Outstanding
102.14
Days Payables Outstanding
187.84
Days of Inventory on Hand
460.21
Receivables Turnover
3.57
Payables Turnover
1.94
Inventory Turnover
0.79
Capex per Share
36.21

Balance Sheet

Cash per Share
1.061,42
Book Value per Share
3.211,82
Tangible Book Value per Share
2334.15
Shareholders Equity per Share
3128.25
Interest Debt per Share
645.74
Debt to Equity
0.2
Debt to Assets
0.13
Net Debt to EBITDA
-1.87
Current Ratio
2.36
Tangible Asset Value
668,38 Bil.
Net Current Asset Value
232,67 Bil.
Invested Capital
838873000000
Working Capital
422,20 Bil.
Intangibles to Total Assets
0.18
Average Receivables
210,91 Bil.
Average Payables
75,02 Bil.
Average Inventory
182626000000
Debt to Market Cap
0.12

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Eisai Co., Ltd. Dividends
Year Dividends Growth
2008 70
2009 140 50%
2010 80 -75%
2011 150 46.67%
2012 70 -114.29%
2013 150 53.33%
2014 1 -14900%
2015 1 0%
2016 71 98.57%
2017 1 -6900%
2018 1 0%
2019 81 98.75%
2020 1 -7900%
2021 1 0%
2022 1 0%
2023 1 0%
2024 1 0%
2025 0 0%

Eisai Co., Ltd. Profile

About Eisai Co., Ltd.

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

CEO
Mr. Haruo Naito
Employee
11.067
Address
4-6-10, Koishikawa
Tokyo, 112-8088

Eisai Co., Ltd. Executives & BODs

Eisai Co., Ltd. Executives & BODs
# Name Age
1 Mitsuru Shomon
Vice President & Chief Financial Officer
70
2 Shin Kato
Vice President, General Counsel & Chief Compliance Officer
70
3 Mr. Masatomi Akana
Senior Vice President, Chief Government Relations Officer & Chief IR Officer
70
4 Mr. Gary Hendler
Senior Vice President & President of EMEA Region
70
5 Dr. Lynn D. Kramer FAAN, M.D.
Vice President & Chief Clinical Officer
70
6 Makoto Hoketsu
Vice President & Chief Information Officer
70
7 Mr. Haruo Naito
Chief Executive Officer, Representative Corporate Officer & Director
70
8 Mr. Keisuke Naito
Representative Corporate Officer, EVice President, Chief Operating Officer & Chief Growth Officer
70
9 Ms. Sayoko Sasaki
Vice President of Corporate Communications & Sustainability
70
10 Ms. Yanhui Feng
Senior Vice President
70

Eisai Co., Ltd. Competitors

BioELife Corp. Logo
BioELife Corp.

LITH

(1.8)
MC Endeavors, Inc. Logo
MC Endeavors, Inc.

MSMY

(1.2)
Kali, Inc. Logo
Kali, Inc.

KALY

(0.0)
HempAmericana, Inc Logo
HempAmericana, Inc

HMPQ

(0.0)
SOHM, Inc. Logo
SOHM, Inc.

SHMN

(0.0)
High Fusion Inc. Logo
High Fusion Inc.

SPLIF

(1.8)
Eisai Co., Ltd. Logo
Eisai Co., Ltd.

ESAIY

()
Silo Wellness Inc. Logo
Silo Wellness Inc.

SILFF

(2.2)
The Flowr Corporation Logo
The Flowr Corporation

FLWPF

(0.8)
SLANG Worldwide Inc. Logo
SLANG Worldwide Inc.

SLGWF

(1.2)
BellRock Brands Inc. Logo
BellRock Brands Inc.

DXBRF

(0.0)